Gene Variations May Help Predict Survival in Mesothelioma Patients Receiving Platinum-based Chemotherapy, Study Finds
News
Variations in the immune-system-related FAS ligand (FASL) gene may help predict how long a malignant pleural mesothelioma patient who received platinum-based chemotherapy can survive without the disease progressing. A study in Egypt showed ... Read more